References
Ng ACT, Holmes DR, Mack MJ et al (2020) Leaflet immobility and thrombosis in transcatheter aortic valve replacement. Eur Heart J 41:3184–3197
Rashid HN, Nasis AM, Gooley RP, Cameron JD, Browon AK (2018) The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prosthesis. Cathet Cardiovasc Interv 92:1414–1416
Abdel-Wahab M, Landt M, Neumann FJ et al (2020) CHOICE Investigators. 5-Year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial. JACC Cardiovasc Interv 13:1071–1082
Kooistra NHM, Abawi M, Voskuil M et al (2020) Randomised comparison of a balloon-expandable and self-expandable valve with quantitative assessment of aortic regurgitation using magnetic resonance imaging. Neth Heart J 28:253–265
Reardon MJ, Feldman TE, Meduri CU et al (2019) Reprise III. Investigators two-year outcomes after transcatheter aortic valve replacement with mechanical vs self-expanding valves: the REPRISE III randomized clinical trial. JAMA Cardiol 4:223–229
Lanz J, Kim WK, Walther T et al (2019) SCOPE I investigators. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 394:1619–1628
Thiele H, Kurz T, Feistritzer HJ et al (2020) Comparison of newer generation self-expandable vs balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J 41:1890–1899
Midha PA, Raghav V, Sharma R et al (2017) The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus. Circulation 136:1598–1609
Jander N, Sommer H, PingPoh C et al (2015) The porcine valve type predicts obstructive thrombosis beyond the first three postoperative months in bioprosthesis in the aortic position. Int J Cardiol 199:90–95
Dangas GD, Tijssen JGP, Wöhrle J et al (2020) GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med 382:120–129
Moreno R, Calvo L, Salinas P et al (2011) Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients. J Invasive Cardiol 23:180–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreno, R., Unverdorben, M., Jurado-Román, A. et al. The risk of valve thrombosis is higher with intra-annular versus supra-annular transcatheter aortic valve prosthesis. A meta-analysis from randomized controlled trials. Clin Res Cardiol 110, 2007–2009 (2021). https://doi.org/10.1007/s00392-021-01818-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-021-01818-x